During Endometriosis Awareness Month, researchers and clinicians are highlighting new developments that could transform how this often misunderstood condition is diagnosed and managed.
One of the most promising breakthroughs is a new blood test designed to help detect endometriosis earlier — without surgery.
The test, called HerResolve endometriosis blood test, has recently become commercially available across several fertility and reproductive medicine clinics in the United States.
Experts say innovations like this could help address one of the biggest challenges in endometriosis care: diagnosis delays that can last years.
Endometriosis: A Global Condition Affecting 1 in 10 Women
Endometriosis affects an estimated 1 in 10 women of reproductive age worldwide.
The condition occurs when tissue similar to the lining of the uterus grows outside the womb, often affecting the ovaries, fallopian tubes, pelvic lining, and sometimes other organs.
Common symptoms include:
- Severe menstrual pain
- Chronic pelvic pain
- Pain during sex
- Fatigue
- Digestive issues
- Difficulty conceiving
Despite its prevalence, many patients face diagnostic delays of 7–10 years, leaving them living with symptoms while searching for answers.
Why Endometriosis Has Been So Difficult to Diagnose
For decades, the only definitive way to diagnose endometriosis has been through Laparoscopy, a minimally invasive surgical procedure that allows doctors to look inside the abdomen and confirm the presence of endometrial-like tissue.
While effective, surgery is not always the ideal first step — particularly for people who are still exploring treatment options or fertility planning.
Doctors typically rely on a combination of:
- Symptom history
- Ultrasound or MRl imaging
- Clinical examination
- Surgical confirmation
This is why a non-invasive diagnostic tool has long been considered one of the most important unmet needs in women’s health.
A New Blood Test for Endometriosis Detection
Biotechnology company HerAnova Lifesciences has now introduced the HerResolve test across a growing network of fertility clinics and reproductive medicine centers.
The test uses advanced multi-omic molecular analysis from a blood sample to identify biological markers associated with endometriosis.
According to validation studies, the test demonstrated diagnostic accuracy comparable to histology-confirmed surgical diagnosis, meaning results closely matched cases confirmed through laparoscopy.
Clinics currently offering the test include:
- Reproductive Partners Medical Group in Southern California
- CNY Fertility, which operates clinics across the United States
Fertility specialists say the ability to identify potential endometriosis earlier could significantly improve treatment planning.
Why Earlier Diagnosis Matters — Especially for Fertility
Endometriosis is one of the leading causes of infertility.
Studies suggest up to 30–50% of women with endometriosis may experience fertility challenges, making early detection especially important for those trying to conceive.
Dr Carrie Wambach, a reproductive endocrinologist at Reproductive Partners Medical Group, says the new test could help fertility specialists move faster when designing treatment plans.
“In fertility care, timing matters. Tools that help us understand what may be affecting a patient earlier allow us to personalise treatment and move to the most effective option sooner.”
Early insight may help doctors decide whether patients should consider treatments such as:
- Blood biomarkers
- Genetic and molecular signatures
- Al-assisted imaging
- MicroRNA detection
- Immune system markers
If validated across larger studies, these technologies could eventually allow endometriosis to be diagnosed through routine testing rather than surgery.
For millions of people living with symptoms, this would represent a major step forward.
Endometriosis Awareness Month: Why Conversations Matter
Endometriosis Awareness Month shines a spotlight on a condition that has historically been under-diagnosed, under-funded, and misunderstood.
Greater awareness is helping to:
- Reduce diagnostic delays
- Improve research funding
- Encourage earlier investigation of symptoms
- Support those navigating fertility challenges
The introduction of blood-based testing is part of a broader movement to improve care and provide patients with earlier answers and more personalised treatment options.
A New Era in Endometriosis Diagnosis
While surgical confirmation remains the current gold standard, innovations like the HerResolve test show that the future of endometriosis diagnosis may look very different.
Earlier detection, less invasive testing, and improved treatment pathways could dramatically improve outcomes for millions of patients worldwide.
And for those living with symptoms, faster answers can mean something incredibly important:
Validation, understanding, and the opportunity to take control of their reproductive health.